Literature DB >> 11126339

Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.

N Lima1, H Cavaliere, M Knobel, A Halpern, G Medeiros-Neto.   

Abstract

OBJECTIVE: In obese men, sex hormone-binding globulin (SHBG) as well as total testosterone (TT) levels are decreased. Data concerning serum free testosterone (FT) levels in obese men are discordant. FT levels are decreased in only some morbidly obese men, consistent with an impairment of the feedback regulatory mechanism. In this study we aimed to verify serum levels of TT and FT in two groups of obese men (BMI < 35.0 kg/m2 and BMI > 35.1 kg/m2) before and after weight loss.
DESIGN: Two groups of obese men (group 1: BMI < or = 35 kg/m2; and group 2: BMI > or =35.1 kg/m2) were studied before and after 6 months of a low energy diet (1200 kcal/day). Every patient received a therapeutic prescription of dexfenfluramine (15 mg b.i.d.) that was maintained for 6 months.
SUBJECTS: Thirty-seven obese men and 20 normal weight men. MEASUREMENTS: Serum sex hormones (TT and FT), serum luteinizing hormone (LH) and insulin were analyzed by RIA assays. Plasma insulin levels, serum TT, FT and LH concentrations were obtained before and after weight loss.
RESULTS: Moderately obese men (BMI = 32.3+/- 1.9 kg/m2) presented significantly decreased TT levels (390+/-120ng/dl) as well as FT (mean+/-s.d.:16.0+/-4.8pg/ml) as compared with normal controls. FT serum levels had a significant and negative correlation with body mass index (BMI), whereas for TT concentrations this correlation was not significant. Serum LH concentrations (4.5+/-2.9mlU/ml) were normal. Insulin levels were elevated in all patients (46.3+/-30.1 microU/ml). After weight loss there was a significant (P< 0.01) increase in TT, FT and LH levels, whereas insulin concentrations significantly decreased. In massively obese men (BMI = 43.0 6.7 kg/m2), TT (320+/-110ng/dl), FT (11.0+/-2.1 pg/ml) and LH (3.1+/-1.3mlU/ml) were decreased and significantly lower as compared with the previous group and normal controls. As expected, after weight loss TT, FT and LH levels increased significantly while insulin concentrations decreased.
CONCLUSIONS: We concluded that FT levels are dependent on the degree of obesity, massively obese men (BMI > or =35.1 kg/m2) being considered as candidates for consistently low FT levels. A functional decrease of LH pulse amplitude and serum LH levels as well as a possible negative action of excess of circulating leptin on the steroidogenesis may be related to the decreased androgens levels in massively obese men.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11126339     DOI: 10.1038/sj.ijo.0801406

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  24 in total

1.  Bone loss in obesity and obstructive sleep apnea: a review of literature.

Authors:  Marlene Chakhtoura; Mona Nasrallah; Hassan Chami
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

Review 2.  Hormonal responses and adaptations to resistance exercise and training.

Authors:  William J Kraemer; Nicholas A Ratamess
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

3.  Hypogonadotropic hypogonadism in a homozygous MC4R mutation carrier and the effect of sibutramine treatment on body weight and obesity-related health risks.

Authors:  Irena Aldhoon Hainerová; Hana Zamrazilová; Dana Sedláčková; Vojtěch Hainer
Journal:  Obes Facts       Date:  2011-07-28       Impact factor: 3.942

Review 4.  Alternative treatment modalities for the hypogonadal patient.

Authors:  Landon W Trost; Mohit Khera
Journal:  Curr Urol Rep       Date:  2014-07       Impact factor: 3.092

5.  Hypogonadotropic hypogonadism in a patient with morbid obesity.

Authors:  Miguel Angel Mollar Puchades; Rosa Cámara Gómez; Maria Isabel del Olmo García; José Luis Ponce Marco; Raquel Segovia Portolés; Pablo Abellán Galiana; Francisco Piñón Sellés
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

6.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

Review 7.  Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.

Authors:  Landon W Trost; John P Mulhall
Journal:  J Sex Med       Date:  2016-05-18       Impact factor: 3.802

8.  Is there a role for body mass index in the assessment of prostate cancer risk on biopsy?

Authors:  Yuanyuan Liang; Norma S Ketchum; Phyllis J Goodman; Eric A Klein; Ian M Thompson
Journal:  J Urol       Date:  2014-04-18       Impact factor: 7.450

9.  Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats.

Authors:  Pilar Cano; Vanesa Jiménez-Ortega; Alvaro Larrad; Carlos F Reyes Toso; Daniel P Cardinali; Ana I Esquifino
Journal:  Endocrine       Date:  2008-05-01       Impact factor: 3.633

10.  Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic.

Authors:  Jorge E Chavarro; Thomas L Toth; Diane L Wright; John D Meeker; Russ Hauser
Journal:  Fertil Steril       Date:  2009-03-03       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.